A 60 Year Old Female Presents With A Tearing

Clinical Presentation

A 60‑year‑old woman arrives at the ophthalmology clinic complaining of persistent tearing (epiphora) from the right eye for the past three months. She describes the discharge as clear, watery, and worsening throughout the day, especially after reading or watching television. Practically speaking, past medical history includes hypertension, well‑controlled type 2 diabetes mellitus, and mild seasonal allergic rhinitis. Day to day, she denies recent trauma, contact‑lens wear, or exposure to irritants. The tearing is not associated with pain, redness, visual loss, or foreign‑body sensation. She has no known ocular surgeries or previous episodes of ocular infection.

The combination of age, chronic watery discharge, and the absence of inflammatory signs points toward a lacrimal drainage system disorder, most commonly nasolacrimal duct obstruction (NLDO). Even so, a comprehensive evaluation must consider a broad differential that includes both ocular surface and nasolacrimal pathologies, systemic diseases, and medication side effects Less friction, more output..

Introduction

Epiphora, the abnormal overflow of tears onto the face, is a frequent complaint in the elderly population. Which means while occasional tearing can be a normal physiologic response to emotional stimuli or irritants, pathologic tearing often signals an underlying obstruction or dysfunction of the lacrimal apparatus. In patients over 60, the prevalence of nasolacrimal duct obstruction rises sharply due to age‑related tissue changes, making it the leading cause of chronic epiphora in this age group. Early recognition and appropriate management are essential to prevent secondary complications such as conjunctivitis, dacryocystitis, or even chronic keratitis.

Anatomy and Physiology of Tear Drainage

Understanding the normal tear pathway is crucial for interpreting clinical findings:

1. Tear Production – The lacrimal gland and accessory glands produce the aqueous layer of the tear film.
2. Distribution – Blinking spreads tears across the cornea and conjunctiva, providing lubrication and antimicrobial protection.
3. Drainage – Tears enter the punctal openings (upper and lower) on the medial eyelid margin, travel through the canaliculi, converge at the common canaliculus, and then flow into the lacrimal sac. From the sac, they descend the nasolacrimal duct and empty into the inferior meatus of the nose.

Any interruption along this pathway—whether from inflammation, fibrosis, or mechanical blockage—can result in epiphora.

Differential Diagnosis

1. Primary Acquired Nasolacrimal Duct Obstruction (PANDO)

• Epidemiology: Most common cause of chronic tearing in adults >50 years.
• Pathophysiology: Age‑related mucosal atrophy, chronic low‑grade inflammation, and fibrosis narrow the duct lumen.
• Clinical clues: Unilateral watery discharge, absence of pain, normal ocular surface, and a positive fluorescein dye disappearance test (delayed clearance).

2. Canalicular Stenosis or Obstruction

• May follow repeated infections, trauma, or iatrogenic injury (e.g., after cataract surgery).
• Presents similarly to PANDO but often with a punctal sac that fills slowly on syringing.

3. Lacrimal Pump Dysfunction (Lacrimal Sac/Canalicular Sphincter Failure)

• Occurs with eyelid malposition (e.g., entropion, ectropion) or facial nerve palsy.
• Tears pool on the ocular surface despite a patent duct.

4. Ocular Surface Disorders

• Dry eye syndrome paradoxically causes reflex tearing due to ocular surface irritation.
• Allergic conjunctivitis can produce watery discharge with itching and redness.

5. Inflammatory or Infectious Nasolacrimal Pathology

• Dacryocystitis (acute or chronic) presents with pain, erythema, and purulent discharge, often preceded by epiphora.
• Sinusitis or nasal polyps can compress the nasolacrimal duct externally.

6. Systemic Medications

• Anticholinergics, antihistamines, and some antidepressants reduce tear production, leading to reflex tearing.
• Beta‑blockers (commonly used for hypertension) may cause ocular surface dryness, again provoking reflex epiphora.

7. Neoplastic Causes

• Rarely, lacrimal sac tumors (e.g., papilloma, carcinoma) obstruct drainage.
• Suspicion rises with firm, non‑compressible swelling and blood‑tinged tears.

Diagnostic Work‑up

1. History and Physical Examination

• Detailed symptom chronology, laterality, aggravating factors, and associated ocular or nasal symptoms.
• Review of systemic diseases (diabetes, autoimmune conditions) and medication list.

2. Slit‑Lamp Examination

• Assess conjunctival hyperemia, corneal staining, and tear meniscus height.
• Look for punctal abnormalities (stenosis, ectropion) and lid position.

3. Fluorescein Dye Disappearance Test (FDDT)

• Instill a small fluorescein drop in the conjunctival sac; observe clearance after 5 minutes.
• Delayed clearance suggests obstruction.

4. Lacrimal Syringing (Probe and Irrigation)

• Introduce a sterile saline solution through the puncta; observe resistance or reflux.
• Patency of the canaliculi and nasolacrimal duct is confirmed if fluid drains into the nose without reflux.

5. Nasolacrimal Duct Imaging

• Dacryocystography (contrast study) or CT dacryocystography for detailed anatomy, especially if surgery is planned.
• Ultrasound biomicroscopy can evaluate soft‑tissue masses.

6. Nasal Endoscopy (if sinonasal disease suspected)

• Visualizes the inferior meatus and assesses for polyps or mucosal edema.

Management Strategies

Conservative Measures

Conservative therapy is rarely curative for true anatomical obstruction but can provide symptomatic relief while awaiting definitive treatment Most people skip this — try not to..

Surgical Options

1. External Dacryocystorhinostomy (DCR)

   • Gold‑standard for PANDO.
   • Involves creating a bony ostium between the lacrimal sac and nasal mucosa, often supported with a silicone stent.
   • Success rates: 90–95 % in experienced hands.

2. Endoscopic Endonasal DCR

   • Performed via the nasal cavity using endoscopic instruments.
   • Advantages: No external scar, shorter recovery, simultaneous treatment of nasal pathology.
   • Comparable success to external DCR when performed by skilled surgeons.

3. Mini‑DCR (Transcanalicular or Endoscopic Laser‑Assisted)

   • Less invasive, suitable for partial obstructions or canalicular stenosis.
   • Lower success rates (70–80 %) but minimal tissue disruption.

4. Balloon Dacryoplasty

   • A catheter with an inflatable balloon dilates the nasolacrimal duct.
   • Often combined with stenting; useful in early‑stage obstruction.

5. Silicone Stenting Alone

   • Temporary stent placement for 3–6 months can maintain patency after balloon dilation or in cases of canalicular scarring.

Post‑operative care includes topical antibiotics, anti‑inflammatory drops, and regular follow‑up to monitor stent position and wound healing Worth keeping that in mind..

Special Considerations in a 60‑Year‑Old Female

• Systemic Health: Hypertension and diabetes can impair wound healing; peri‑operative glycemic control is essential.
• Bone Density: Post‑menopausal osteoporosis may affect the integrity of the nasal wall during external DCR; careful drilling and use of fine instruments reduce fracture risk.
• Medication Review: Many antihypertensive agents (e.g., diuretics) may exacerbate ocular surface dryness, contributing to reflex tearing. Coordination with the primary care physician can optimize systemic therapy.
• Psychosocial Impact: Chronic tearing can cause social embarrassment and affect quality of life. Counseling and reassurance about the high success rates of DCR can alleviate anxiety.

Frequently Asked Questions (FAQ)

Q1. How long does it take to recover after external DCR?
A: Most patients resume normal activities within 1–2 weeks. Full resolution of tearing may take 4–6 weeks as the surgical ostium matures Surprisingly effective..

Q2. Will the surgery leave a visible scar?
A: The external incision is typically 10–12 mm and placed along the natural skin crease near the nose, making the scar virtually invisible after healing.

Q3. Can epiphora recur after successful surgery?
A: Recurrence occurs in <10 % of cases, often due to scar formation or new nasal pathology. Prompt evaluation can address recurrent obstruction early.

Q4. Are there non‑surgical alternatives for nasolacrimal duct obstruction?
A: Balloon dacryoplasty and silicone stenting are minimally invasive options, but long‑term success is lower than conventional DCR Small thing, real impact. And it works..

Q5. Should I avoid contact lenses during treatment?
A: If the patient uses contact lenses, they should be discontinued until the lacrimal system is evaluated, as lenses can mask or exacerbate ocular surface irritation.

Conclusion

A 60‑year‑old woman presenting with chronic, unilateral tearing most likely suffers from primary acquired nasolacrimal duct obstruction, a condition that becomes increasingly prevalent with age. A systematic approach—starting with a thorough history, targeted ocular examination, and confirmatory tests such as the fluorescein dye disappearance test and lacrimal syringing—allows clinicians to differentiate PANDO from other causes of epiphora, including ocular surface disease, lid malposition, and systemic medication effects.

When obstruction is confirmed, surgical intervention, particularly external or endoscopic dacryocystorhinostomy, offers a definitive cure with high success rates and minimal morbidity. Tailoring the surgical plan to the patient’s systemic health, bone quality, and personal preferences ensures optimal outcomes and restores both functional vision and psychosocial well‑being.

Early recognition and appropriate management of tearing in the elderly not only alleviates a bothersome symptom but also prevents secondary complications such as chronic conjunctivitis or dacryocystitis. By integrating a patient‑centered diagnostic algorithm with evidence‑based therapeutic options, eye care professionals can deliver compassionate, effective care that improves the quality of life for older adults facing this common yet treatable condition.